{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:45:07Z","timestamp":1791233107230,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["CDEIGENT 2020-02"],"award-info":[{"award-number":["CDEIGENT 2020-02"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021SGR-01545"],"award-info":[{"award-number":["2021SGR-01545"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2021-125801OB-100"],"award-info":[{"award-number":["PID2021-125801OB-100"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2021-122331OB-I00"],"award-info":[{"award-number":["PID2021-122331OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PLEC2022-009356, PDC2022-133577-I00"],"award-info":[{"award-number":["PLEC2022-009356, PDC2022-133577-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["RED2024-153634-T"],"award-info":[{"award-number":["RED2024-153634-T"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-026-01002-x","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:07:04Z","timestamp":1779725224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intravesical mycobacteria reshape bladder and gut microbiota in a murine bladder cancer model"],"prefix":"10.1038","volume":"12","author":[{"given":"V\u00edctor","family":"Campo-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Guallar-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Cabrera-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Herrero-Abad\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnau","family":"Segu\u00ed-Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Torres-Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Cano-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Comas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Torrents","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Juli\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"crossref","unstructured":"Saginala, K. et al. Epidemiology of bladder cancer. Med. Sci. 8, 15 (2020).","DOI":"10.3390\/medsci8010015"},{"key":"1002_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/ITT.S202006","volume":"9","author":"S Guallar-Garrido","year":"2020","unstructured":"Guallar-Garrido, S. & Juli\u00e1n, E. Bacillus Calmette-Gu\u00e9rin (BCG) therapy for bladder cancer: an update. Immunotargets Ther. 9, 1 (2020).","journal-title":"Immunotargets Ther."},{"key":"1002_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41585-021-00481-1","volume":"18","author":"N Lobo","year":"2021","unstructured":"Lobo, N. et al. 100 years of Bacillus Calmette-Gu\u00e9rin immunotherapy: from cattle to COVID-19. Nat. Rev. Urol. 18, 611\u2013622 (2021).","journal-title":"Nat. Rev. Urol."},{"key":"1002_CR4","doi-asserted-by":"crossref","unstructured":"Guallar-Garrido, S. et al. Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-\u03b3\/IL-17 release in bladder cancer treatment. Oncoimmunology 11, 2051845 (2022).","DOI":"10.1080\/2162402X.2022.2051845"},{"key":"1002_CR5","doi-asserted-by":"crossref","unstructured":"James, C. et al. Impact of intravesical Bacillus Calmette-Gu\u00e9rin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer. Front. Cell. Infect. Microbiol. 13, 1125809 (2023).","DOI":"10.3389\/fcimb.2023.1125809"},{"key":"1002_CR6","doi-asserted-by":"crossref","unstructured":"Min, K. et al. Differential urinary microbiome and its metabolic footprint in bladder cancer patients following BCG treatment. Int. J. Mol. Sci. 25, 11157 (2024).","DOI":"10.3390\/ijms252011157"},{"key":"1002_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.euf.2015.03.003","volume":"2","author":"E Noguera-Ortega","year":"2016","unstructured":"Noguera-Ortega, E. et al. Nonpathogenic Mycobacterium brumae inhibits bladder cancer growth in vitro, ex vivo, and in vivo. Eur. Urol. Focus 2, 67\u201376 (2016).","journal-title":"Eur. Urol. Focus"},{"key":"1002_CR8","doi-asserted-by":"crossref","unstructured":"Guallar-Garrido, S., Ez, V., S\u00e1nchez-Chardi, A., Luquin, M. & Juli\u00e1n, E. Each Mycobacterium requires a specific culture medium composition for triggering an optimized immunomodulatory and antitumoral effect. Microorganisms 8, 734 (2020).","DOI":"10.3390\/microorganisms8050734"},{"key":"1002_CR9","doi-asserted-by":"crossref","unstructured":"Bach-Griera, M. et al. Mycolicibacterium brumae is a safe and non-toxic immunomodulatory agent for cancer treatment. Vaccines. 8, 198 (2020).","DOI":"10.3390\/vaccines8020198"},{"key":"1002_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11884-016-0345-8","volume":"11","author":"K Thomas-White","year":"2016","unstructured":"Thomas-White, K., Brady, M., Wolfe, A. J. & Mueller, E. R. The bladder is not sterile: history and current discoveries on the urinary microbiome. Curr. Bladder Dysfunct. Rep. 11, 18 (2016).","journal-title":"Curr. Bladder Dysfunct. Rep."},{"key":"1002_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/life13030812","volume":"13","author":"NA Heidar","year":"2023","unstructured":"Heidar, N. A., Bhat, T. A., Shabir, U. & Hussein, A. A. The urinary microbiome and bladder cancer. Life 13, 812 (2023).","journal-title":"Life"},{"key":"1002_CR12","doi-asserted-by":"crossref","unstructured":"Friedrich, V. & Choi, H. W. The urinary microbiome: role in bladder cancer and treatment. Diagnostics 12, 2068 (2022).","DOI":"10.3390\/diagnostics12092068"},{"key":"1002_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.urology.2018.12.034","volume":"126","author":"P Bajic","year":"2019","unstructured":"Bajic, P., Wolfe, A. J. & Gupta, G. N. The urinary microbiome: implications in bladder cancer pathogenesis and therapeutics. Urology 126, 10\u201315 (2019).","journal-title":"Urology"},{"key":"1002_CR14","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. Bladder cancer-associated microbiota: recent advances and future perspectives. Heliyon 9, e13012 (2023).","DOI":"10.1016\/j.heliyon.2023.e13012"},{"key":"1002_CR15","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1099\/jmm.0.001058","volume":"68","author":"H Bi","year":"2019","unstructured":"Bi, H. et al. Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer. J. Med. Microbiol. 68, 1471\u20131478 (2019).","journal-title":"J. Med. Microbiol."},{"key":"1002_CR16","doi-asserted-by":"crossref","unstructured":"Bu\u010devi\u0107 Popovi\u0107, V. et al. The urinary microbiome associated with bladder cancer. Sci. Rep. 8, 12157 (2018).","DOI":"10.1038\/s41598-018-29054-w"},{"key":"1002_CR17","doi-asserted-by":"publisher","first-page":"370.e9","DOI":"10.1016\/j.urolonc.2020.12.011","volume":"39","author":"AA Hussein","year":"2021","unstructured":"Hussein, A. A. et al. Investigating the association between the urinary microbiome and bladder cancer: an exploratory study. Urol. Oncol. 39, 370.e9\u2013370.e19 (2021).","journal-title":"Urol. Oncol."},{"key":"1002_CR18","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1002\/cam4.2419","volume":"8","author":"F Liu","year":"2019","unstructured":"Liu, F. et al. Dysbiosis signatures of the microbial profile in tissue from bladder cancer. Cancer Med. 8, 6904\u20136914 (2019).","journal-title":"Cancer Med."},{"key":"1002_CR19","doi-asserted-by":"crossref","unstructured":"Hourigan, S. K. et al. Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy. BMC Urol. 20, 5 (2020).","DOI":"10.1186\/s12894-020-0576-z"},{"key":"1002_CR20","doi-asserted-by":"publisher","first-page":"617002","DOI":"10.3389\/fcimb.2021.617002","volume":"11","author":"V Perez-Carrasco","year":"2021","unstructured":"Perez-Carrasco, V., Soriano-Lerma, A., Soriano, M., Guti\u00e9rrez-Fern\u00e1ndez, J. & Garcia-Salcedo, J. A. Urinary microbiome: yin and yang of the urinary tract. Front. Cell. Infect. Microbiol. 11, 617002 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1002_CR21","doi-asserted-by":"crossref","unstructured":"Bieri, U. et al. Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocol. BMJ Open 12, e061421 (2022).","DOI":"10.1136\/bmjopen-2022-061421"},{"key":"1002_CR22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","volume":"28","author":"EM Park","year":"2022","unstructured":"Park, E. M. et al. Targeting the gut and tumor microbiota in cancer. Nat. Med. 28, 690\u2013703 (2022).","journal-title":"Nat. Med."},{"key":"1002_CR23","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.7150\/ijbs.69331","volume":"18","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Gut microbiome in gastrointestinal cancer: a friend or foe? Int. J. Biol. Sci. 18, 4101 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"1002_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ncpuro1199","volume":"5","author":"MA O\u2019Donnell","year":"2008","unstructured":"O\u2019Donnell, M. A. Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer? Nat. Clin. Pract. Urol. 5, 526\u2013527 (2008).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"1002_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.eururo.2004.09.011","volume":"47","author":"CE Hoesl","year":"2005","unstructured":"Hoesl, C. E. & Altwein, J. E. The probiotic approach: an alternative treatment option in urology. Eur. Urol. 47, 288\u2013296 (2005).","journal-title":"Eur. Urol."},{"key":"1002_CR26","first-page":"395","volume":"29","author":"C He","year":"2020","unstructured":"He, C. et al. Gut microbial composition changes in bladder cancer patients: a case-control study in Harbin, China. Asia Pac. J. Clin. Nutr. 29, 395\u2013403 (2020).","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"1002_CR27","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1128\/JB.01485-09","volume":"192","author":"E Juli\u00e1n","year":"2010","unstructured":"Juli\u00e1n, E. et al. Microscopic cords, a virulence-related characteristic of Mycobacterium tuberculosis, are also present in nonpathogenic mycobacteria. J. Bacteriol. 192, 1751 (2010).","journal-title":"J. Bacteriol."},{"key":"1002_CR28","doi-asserted-by":"crossref","unstructured":"Noguera-Ortega, E. et al. Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice. Sci. Rep. 8, 15102 (2018).","DOI":"10.1038\/s41598-018-33253-w"},{"key":"1002_CR29","doi-asserted-by":"crossref","unstructured":"Senserrich, J. et al. Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition. Front. Immunol. 13, 993401 (2022).","DOI":"10.3389\/fimmu.2022.993401"},{"key":"1002_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep27232","volume":"6","author":"E Noguera-Ortega","year":"2016","unstructured":"Noguera-Ortega, E. et al. Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment. Sci. Rep. 6, 1\u201312 (2016).","journal-title":"Sci. Rep."},{"key":"1002_CR31","doi-asserted-by":"crossref","unstructured":"Villasante, A. et al. In-depth analysis of swim bladder-associated microbiota in rainbow trout (Oncorhynchus mykiss). Sci. Rep. 9, 8974 (2019).","DOI":"10.1038\/s41598-019-45451-1"},{"key":"1002_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1875036201307010001","volume":"7","author":"E Aronesty","year":"2013","unstructured":"Aronesty, E. Comparison of sequencing utility programs. Open Bioinform. J. 7, 1\u20138 (2013).","journal-title":"Open Bioinform. J."},{"key":"1002_CR33","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","volume":"26","author":"RC Edgar","year":"2010","unstructured":"Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460\u20132461 (2010).","journal-title":"Bioinformatics"},{"key":"1002_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335\u2013336 (2010).","journal-title":"Nat. Methods"},{"key":"1002_CR35","doi-asserted-by":"crossref","unstructured":"Bokulich, N. A. et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin. Microbiome 6, 90 (2018).","DOI":"10.1186\/s40168-018-0470-z"},{"key":"1002_CR36","doi-asserted-by":"crossref","unstructured":"Cole, J. R. et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 42, D633\u2013D642 (2014).","DOI":"10.1093\/nar\/gkt1244"},{"key":"1002_CR37","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"1002_CR38","doi-asserted-by":"crossref","unstructured":"Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2--approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).","DOI":"10.1371\/journal.pone.0009490"},{"key":"1002_CR39","doi-asserted-by":"publisher","unstructured":"Wickham, H. ggplot2. https:\/\/doi.org\/10.1007\/978-0-387-98141-3 (2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"1002_CR40","doi-asserted-by":"crossref","unstructured":"Chen, H. & Boutros, P. C. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics 12, 35 (2011).","DOI":"10.1186\/1471-2105-12-35"},{"key":"1002_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome Census Data. PLoS ONE 8, e61217 (2013).","journal-title":"PLoS ONE"},{"key":"1002_CR42","doi-asserted-by":"crossref","unstructured":"Jiang, H. et al. Multimedia: multimodal mediation analysis of microbiome data. Microbiol. Spectr. 13, e0113124 (2025).","DOI":"10.1128\/spectrum.01131-24"},{"key":"1002_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/scitranslmed.3010473","volume":"7","author":"L Zitvogel","year":"2015","unstructured":"Zitvogel, L. et al. Cancer and the gut microbiota: an unexpected link. Sci. Transl. Med. 7, 271 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1002_CR44","doi-asserted-by":"publisher","first-page":"5968814","DOI":"10.1155\/2022\/5968814","volume":"2022","author":"M Chu","year":"2022","unstructured":"Chu, M. & Zhang, X. Bacterial atlas of mouse gut microbiota. Cell. Microbiol. 2022, 5968814 (2022).","journal-title":"Cell. Microbiol."},{"key":"1002_CR45","doi-asserted-by":"publisher","first-page":"123865","DOI":"10.3389\/fmicb.2015.00020","volume":"6","author":"Z Gao","year":"2015","unstructured":"Gao, Z., Guo, B., Gao, R., Zhu, Q. & Qin, H. Microbiota disbiosis is associated with colorectal cancer. Front. Microbiol. 6, 123865 (2015).","journal-title":"Front. Microbiol."},{"key":"1002_CR46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41591-024-02803-3","volume":"30","author":"JR Bj\u00f6rk","year":"2024","unstructured":"Bj\u00f6rk, J. R. et al. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma. Nat. Med. 30, 785\u2013796 (2024).","journal-title":"Nat. Med."},{"key":"1002_CR47","doi-asserted-by":"publisher","first-page":"101478","DOI":"10.1016\/j.xcrm.2024.101478","volume":"5","author":"X Kang","year":"2024","unstructured":"Kang, X., Lau, H. C. H. & Yu, J. Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy. Cell Rep. Med. 5, 101478 (2024).","journal-title":"Cell Rep. Med."},{"key":"1002_CR48","doi-asserted-by":"crossref","unstructured":"Lei, W., Zhou, K., Lei, Y., Li, Q. & Zhu, H. Gut microbiota shapes cancer immunotherapy responses. NPJ Biofilms Microbiomes 11, 143 (2025).","DOI":"10.1038\/s41522-025-00786-8"},{"key":"1002_CR49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/microorganisms8040573","volume":"8","author":"M Vacca","year":"2020","unstructured":"Vacca, M. et al. The controversial role of human gut Lachnospiraceae. Microorganisms 8, 573 (2020).","journal-title":"Microorganisms"},{"key":"1002_CR50","doi-asserted-by":"crossref","unstructured":"Riazati, N., Kable, M. E. & Stephensen, C. B. Association of intestinal bacteria with immune activation in a cohort of healthy adults. Microbiol. Spectr. 11, e0102723 (2023).","DOI":"10.1128\/spectrum.01027-23"},{"key":"1002_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","volume":"28","author":"L Derosa","year":"2022","unstructured":"Derosa, L. et al. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat. Med. 28, 315\u2013324 (2022).","journal-title":"Nat. Med."},{"key":"1002_CR52","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.3390\/nu16162660","volume":"16","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Exploration of the Muribaculaceae family in the gut microbiota: diversity, metabolism, and function. Nutrients 16, 2660 (2024).","journal-title":"Nutrients"},{"key":"1002_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97\u2013103 (2018).","journal-title":"Science"},{"key":"1002_CR54","doi-asserted-by":"crossref","unstructured":"Zheng, Y. et al. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. J. Immunother. Cancer 7, 193 (2019).","DOI":"10.1186\/s40425-019-0650-9"},{"key":"1002_CR55","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.3390\/ijms20174155","volume":"20","author":"S Temraz","year":"2019","unstructured":"Temraz, S. et al. Gut microbiome: A promising biomarker for immunotherapy in colorectal cancer. Int. J. Mol. Sci. 20, 4155 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1002_CR56","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ismej.2011.109","volume":"6","author":"T Wang","year":"2012","unstructured":"Wang, T. et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 6, 320\u2013329 (2012).","journal-title":"ISME J."},{"key":"1002_CR57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220 (2012).","journal-title":"Nature"},{"key":"1002_CR58","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"Zheng, D., Liwinski, T. & Elinav, E. Interaction between microbiota and immunity in health and disease. Cell Res. 30, 492\u2013506 (2020).","journal-title":"Cell Res."},{"key":"1002_CR59","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41590-022-01354-4","volume":"23","author":"M Jeyanathan","year":"2022","unstructured":"Jeyanathan, M. et al. Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut\u2013lung axis. Nat. Immunol. 23, 1687\u20131702 (2022).","journal-title":"Nat. Immunol."},{"key":"1002_CR60","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41396-023-01483-0","volume":"17","author":"J Sun","year":"2023","unstructured":"Sun, J., Chen, F. & Wu, G. Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy. ISME J. 17, 1535\u20131551 (2023).","journal-title":"ISME J."},{"key":"1002_CR61","doi-asserted-by":"crossref","unstructured":"Liu, Y., Yang, C., Zhang, Z. & Jiang, H. Gut microbiota dysbiosis accelerates prostate cancer progression through increased LPCAT1 expression and enhanced DNA Repair Pathways. Front. Oncol. 11, 679712 (2021).","DOI":"10.3389\/fonc.2021.679712"},{"key":"1002_CR62","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Integrated microbiome and metabolome analysis reveals the interaction between intestinal flora and serum metabolites as potential biomarkers in hepatocellular carcinoma patients. Front. Cell. Infect. Microbiol. 13, 1170748 (2023).","DOI":"10.3389\/fcimb.2023.1170748"},{"key":"1002_CR63","doi-asserted-by":"publisher","first-page":"522172","DOI":"10.3389\/fimmu.2020.00906","volume":"11","author":"BJ Parker","year":"2020","unstructured":"Parker, B. J., Wearsch, P. A., Veloo, A. C. M. & Rodriguez-Palacios, A. The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front. Immunol. 11, 522172 (2020).","journal-title":"Front. Immunol."},{"key":"1002_CR64","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida, N. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967 (2013).","journal-title":"Science"},{"key":"1002_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1099\/ijsem.0.003698","volume":"70","author":"KN Haas","year":"2020","unstructured":"Haas, K. N. & Blanchard, J. L. Reclassification of the Clostridium clostridioforme and Clostridium sphenoides clades as Enterocloster gen. nov. and Lacrimispora gen. nov., including reclassification of 15 taxa. Int. J. Syst. Evol. Microbiol. 70, 23\u201334 (2020).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"1002_CR66","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41579-023-00929-8","volume":"21","author":"A Taglialegna","year":"2023","unstructured":"Taglialegna, A. Enterocloster undermine cancer immunotherapy. Nat. Rev. Microbiol. 21, 485\u2013485 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1002_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0637-2","volume":"7","author":"I Lagkouvardos","year":"2019","unstructured":"Lagkouvardos, I. et al. Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family. Microbiome 7, 28 (2019).","journal-title":"Microbiome"},{"key":"1002_CR68","doi-asserted-by":"crossref","unstructured":"Hiraishi, K. et al. Lactulose modulates the structure of gut microbiota and alleviates colitis-associated tumorigenesis. Nutrients 14, 649 (2022).","DOI":"10.3390\/nu14030649"},{"key":"1002_CR69","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1099\/ijsem.0.001643","volume":"67","author":"KN Haas","year":"2017","unstructured":"Haas, K. N. & Blanchard, J. L. Kineothrix alysoides, gen. Nov., sp. nov., a saccharolytic butyrate-producer within the family Lachnospiraceae. Int. J. Syst. Evol. Microbiol. 67, 402\u2013410 (2017).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"1002_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-41160-y","volume":"13","author":"KJ Choi","year":"2023","unstructured":"Choi, K. J., Yoon, M. Y., Kim, J. E. & Yoon, S. S. Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance. Sci. Rep. 13, 1\u201313 (2023).","journal-title":"Sci. Rep."},{"key":"1002_CR71","doi-asserted-by":"publisher","first-page":"100642","DOI":"10.1016\/j.xcrm.2022.100642","volume":"3","author":"L Li","year":"2022","unstructured":"Li, L. & McAllister, F. Too much water drowned the miller: Akkermansia determines immunotherapy responses. Cell Rep. Med. 3, 100642 (2022).","journal-title":"Cell Rep. Med."},{"key":"1002_CR72","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. Akkermansia supplementation reverses the tumor-promoting effect of the fecal microbiota transplantation in ovarian cancer. Cell Rep. 41, 111890 (2022).","DOI":"10.1016\/j.celrep.2022.111890"},{"key":"1002_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-025-00678-x","volume":"11","author":"J Sun","year":"2025","unstructured":"Sun, J. et al. Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation. npj Biofilms Microbiomes 11, 1\u201320 (2025).","journal-title":"npj Biofilms Microbiomes"},{"key":"1002_CR74","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/cancers15030866","volume":"15","author":"H Pandey","year":"2023","unstructured":"Pandey, H., Tang, D. W. T., Wong, S. H. & Lal, D. Gut microbiota in colorectal cancer: Biological role and therapeutic opportunities. Cancers 15, 866 (2023).","journal-title":"Cancers"},{"key":"1002_CR75","doi-asserted-by":"publisher","first-page":"1374944","DOI":"10.3389\/fcimb.2024.1374944","volume":"14","author":"K Lou","year":"2024","unstructured":"Lou, K. et al. Research progress on the microbiota in bladder cancer tumors. Front. Cell. Infect. Microbiol. 14, 1374944 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1002_CR76","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.chom.2021.03.016","volume":"29","author":"C Xing","year":"2021","unstructured":"Xing, C. et al. Microbiota regulate innate immune signaling and protective immunity against cancer. Cell Host Microbe 29, 959\u2013974.e7 (2021).","journal-title":"Cell Host Microbe"},{"key":"1002_CR77","doi-asserted-by":"publisher","first-page":"744606","DOI":"10.3389\/fcimb.2021.744606","volume":"11","author":"SM Ahmad Kendong","year":"2021","unstructured":"Ahmad Kendong, S. M., Raja Ali, R. A., Nawawi, K. N. M., Ahmad, H. F. & Mokhtar, N. M. Gut dysbiosis and intestinal barrier dysfunction: potential explanation for early-onset colorectal cancer. Front. Cell. Infect. Microbiol. 11, 744606 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1002_CR78","doi-asserted-by":"crossref","unstructured":"Sharon, B. M. et al. Genetic and functional enrichments associated with Enterococcus faecalis isolated from the urinary tract. mBio 14, e0251523 (2023).","DOI":"10.1128\/mbio.02515-23"},{"key":"1002_CR79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91\u201397 (2018).","journal-title":"Science"},{"key":"1002_CR80","doi-asserted-by":"crossref","unstructured":"Parra-Grande, M. et al. Profiling the bladder microbiota in patients with bladder cancer. Front. Microbiol. 12, 718776 (2022).","DOI":"10.3389\/fmicb.2021.718776"},{"key":"1002_CR81","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.euo.2020.04.002","volume":"3","author":"F Pederzoli","year":"2020","unstructured":"Pederzoli, F. et al. Sex-specific alterations in the urinary and tissue microbiome in therapy-na\u00efve urothelial bladder cancer patients. Eur. Urol. Oncol. 3, 784\u2013788 (2020).","journal-title":"Eur. Urol. Oncol."},{"key":"1002_CR82","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/diagnostics13010084","volume":"13","author":"YN Gwon","year":"2022","unstructured":"Gwon, Y. N. et al. Microbiome in bladder cancer: a systematic review. Diagnostics 13, 84 (2022).","journal-title":"Diagnostics"},{"key":"1002_CR83","doi-asserted-by":"publisher","first-page":"569","DOI":"10.4111\/icu.20220124","volume":"63","author":"HK Ahn","year":"2022","unstructured":"Ahn, H. K., Kim, K., Park, J. & Kim, K. H. Urinary microbiome profile in men with genitourinary malignancies. Investig. Clin. Urol. 63, 569\u2013576 (2022).","journal-title":"Investig. Clin. Urol."},{"key":"1002_CR84","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/antibiotics12040778","volume":"12","author":"A Lerner","year":"2023","unstructured":"Lerner, A. et al. Enterococcal urinary tract infections: a review of the pathogenicity, epidemiology, and treatment. Antibiotics 12, 778 (2023).","journal-title":"Antibiotics"},{"key":"1002_CR85","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/applmicrobiol1030029","volume":"1","author":"HW Choi","year":"2021","unstructured":"Choi, H. W., Lee, K. W. & Kim, Y. H. The microbiome\u2019s function in disorders of the urinary bladder. Appl. Microbiol. 1, 445\u2013459 (2021).","journal-title":"Appl. Microbiol."},{"key":"1002_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13817-6","volume":"25","author":"Z Sheng","year":"2025","unstructured":"Sheng, Z. et al. The role of urinary microbiota in primary and recurrent bladder cancer: insights from a propensity score matching study. BMC Cancer 25, 468 (2025).","journal-title":"BMC Cancer"}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01002-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:37:50Z","timestamp":1787006270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-01002-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1038\/s41522-026-01002-x","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"158"}}